Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Monitoring for adverse effects in clinical treatments is crucial.

The ginseng market has potential for growth and needs new products and better marketing.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

A blood pressure drug, diltiazem, may also help treat influenza.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Innovative methods are reducing animal testing and improving biomedical research.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.